Abstract
DIABETES IS associated with a 2- to 4-fold increase in coronary heart disease (CHD) (1–3). In the overall population, clinically established CHD is associated with a 3- to 7-fold increase in CHD mortality (4). Plasma cholesterol levels are a strong predictor of risk in patients with clinical CHD (4) and diabetes (3). The much higher risk of CHD in patients with clinical CHD and diabetes has led both the National Cholesterol Education Program (NCEP) (5) and the American Diabetes Association (ADA) (6) to recommend lower goals for low-density lipoprotein cholesterol (LDL-C) in these risk groups.